Le Lézard
Classified in: Health
Subject: RCL

Sunstar Americas Inc. Issues Voluntary Nationwide Recall of Paroex® Chlorhexidine Gluconate Oral Rinse USP, 0.12% due to microbial contamination


CHICAGO, Oct. 27, 2020 /PRNewswire/ -- Sunstar Americas, Inc. (SAI) is voluntarily recalling Paroex® Chlorhexidine Gluconate Oral Rinse USP, 0.12% products bearing an expiration date from 6/30/22 ? 9/30/22 (see specific lots below) to the consumer level.  This product may be contaminated with the bacteria Burkholderia lata.

Use of the defective product in the immunocompetent host may result in oral and, potentially, systemic infections requiring antibacterial therapy. In the most at-risk populations, the use of the defective product may result in life-threatening infections, such as pneumonia and bacteremia. To date, no adverse events have been reported to SAI related to this recall.

The prescription oral rinse product, available through healthcare professionals only, is indicated for use as part of a professional program for the treatment of gingivitis and is packaged as follows:

Paroex was distributed Nationwide to Dental offices, Dental distributors, Pharmaceutical wholesalers, Dental schools, and Pharmacies. 

SAI is notifying its direct distributors and customers by USPS Priority mail and is arranging for return of all recalled products.  Patients, pharmacies, and healthcare facilities in possession of these products should stop using and dispensing immediately.

Consumers with questions regarding this recall can contact SAI by phone at 1-800-528-8537 or email [email protected] on Monday-Friday from 8am-5pm CST.  Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to using this drug product.

Affected products and lot numbers follow below:

AFFECTED LOTS

Product name: Paroex® Chlorhexidine Gluconate Oral Rinse USP, 0.12%
NDC # 052376-021-02  P/N 1789P 16 fl oz

Lot #

Exp Date

Lot #

Exp Date

Lot #

Exp Date

C170FY

6/30/22

C191KT

7/31/22

C205BL

7/31/22

C170FZ

6/30/22

C191KU

7/31/22

C205BM

7/31/22

C170GA

6/30/22

C191KW

7/31/22

C205BN

7/31/22

C170GB

6/30/22

C191KX

7/31/22

C219DS

8/31/22

C170GC

6/30/22

C191KY

7/31/22

C240GM

9/30/22

C177GP

6/30/22

C198LJ

7/31/22

C219DK

8/31/22

C177GQ

6/30/22

C198LK

7/31/22

C219DL

8/31/22

C177GR

6/30/22

C198LL

7/31/22

C219DM

8/31/22

C240GP

9/30/22

 C198LM

7/31/22

C219DN

8/31/22

C240GQ

9/30/22

C205BH

7/31/22

C219DP

8/31/22

C240GR

9/30/22

C205BJ

7/31/22

C219DQ

8/31/22

C191KS

7/31/22

C205BK

7/31/22

C219DR

8/31/22

Product name: Paroex® Chlorhexidine Gluconate Oral Rinse USP, 0.12%
NDC # 052376-021-04  P/N 1788P 4.0 fl oz

Lot #:  C191KR  EXP Date:  07/31/22

Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail or by fax.

Sunstar is committed to delivering safe, fully compliant products of the highest quality and is taking necessary steps to prevent future occurrence of this issue.

This recall is being conducted with the knowledge of the U.S. Food and Drug Administration.

About Sunstar Americas Inc.

Sunstar Americas, Inc., a member of the Sunstar Group of companies, is a global organization headquartered in Switzerland that is a leader in the oral care industry and the manufacturer and distributor of the GUM and Butler Brands.

For more information:
Contact us:
Phone: 1-800-528-8537
Email: [email protected]
Visit us at:
https://www.gumbrand.com/news-announcements

Company Contact:
Greg Belair
847-794-4241
[email protected] 

SOURCE Sunstar


These press releases may also interest you

at 07:32
Duchesnay Pharmaceutical Group (DPG), one of the eight companies across the country chosen to participate in the Government of Canada's Global Hypergrowth Project, is very proud to announce that it has been awarded the Parity Certificationtm by Women...

at 06:30
The global microscopy market is poised for significant growth, expected to reach USD 10.6 billion by 2029 from USD 8.1 billion in 2024, growing at a CAGR of 5.4%. Key drivers include rising cases of chronic diseases necessitating effective...

at 06:25
Genexine (KOSDAQ: 095700), a publicly-listed, clinical-stage Korean biopharmaceutical company committed to the discovery and development of novel biologics for the treatment of serious unmet medical needs, announced a merger with EPD Biotherapeutics...

at 06:03
The IAMStm brand, proudly part of the Mars family of brands, announced today the launch of the IAMStm Puppy Hub and Kitten Hub, two online tools featuring expert knowledge and advice for new and soon-to-be pet parents. Each Hub will bring...

at 06:00
Today, TELUS Health announced a collaboration with Nova Scotia Health (NSH) to enable residents of Nova Scotia to access their primary care information through the YourHealthNS app. This health data interoperability initiative marks the first...

at 05:30
The global Digital Healthcare Market, valued at $220.10 billion in 2024, is on a trajectory of rapid expansion, with projections indicating it will soar to $836.10 billion by 2031, growing at a compound annual growth rate (CAGR) of 21% from 2024 to...



News published on and distributed by: